BOGOTA, Colombia – The Mexican health surveillance agency Cofepris issued an alert about the presence in the country of counterfeited batches of Herceptin (trastuzumab, Roche Holding AG). The alert followed an investigation conducted by the agency after the Swiss drug maker filed a complaint and warned the federal authorities of the counterfeited product in the market.